Jeollabuk-do, South Korea

Myeongcheol Kil

USPTO Granted Patents = 3 


Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jeollabuk-do, KR (2018 - 2019)
  • Iksan-Si, KR (2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Myeongcheol Kil: Innovator in Pharmaceutical Formulations

Introduction

Myeongcheol Kil is a notable inventor based in Jeollabuk-do, South Korea. He has made significant contributions to the field of pharmaceutical formulations, holding three patents that showcase his innovative approach to drug delivery systems.

Latest Patents

One of his latest patents is a tadalafil free base-containing film dosage form that utilizes polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as a dispersion stabilizer. This invention relates to a film formulation for oral administration, which maximizes the dispersion stability of tadalafil free base in the film. The addition of a dispersion stabilizing agent in small amounts minimizes the likelihood of a reagglomeration phenomenon of tadalafil free base particles and significantly reduces the amount of bubbles generated during the production process.

Another significant patent is a pharmaceutical preparation for masked taste oral administration containing clomipramine. This preparation comprises clomipramine or a pharmaceutically acceptable salt thereof, along with a cation exchange resin and an anion polymer as a taste masking agent. This innovation allows for the oral administration of clomipramine while effectively masking its unique bitter, spicy, and burning tastes, thereby improving the convenience of drug intake and portability.

Career Highlights

Myeongcheol Kil is currently associated with CTC Bio, Inc., where he continues to develop innovative pharmaceutical solutions. His work focuses on enhancing drug formulations to improve patient compliance and therapeutic outcomes.

Collaborations

He collaborates with talented coworkers, including Hong Ryeol Jeon and Do-Woo Kwon, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Myeongcheol Kil's contributions to pharmaceutical formulations demonstrate his commitment to improving drug delivery systems. His innovative patents reflect a deep understanding of the challenges in the field and a dedication to enhancing patient experiences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…